In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide

K.M.L. Crommentuyn; J.H.M. Schellens; J.D. van den Berg; J.H. Beijnen

In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide

K.M.L. Crommentuyn
, J.H.M. Schellens
, J.D. van den Berg
, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	345-366
Number of pages	22
Journal	Cancer Treatment Reviews
Volume	24
Publication status	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

Cite this

@article{fdb442c53ccd4addabd3b5af9490e682,

title = "In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "K.M.L. Crommentuyn and J.H.M. Schellens and \{van den Berg\}, J.D. and J.H. Beijnen",

year = "1998",

language = "Undefined/Unknown",

volume = "24",

pages = "345--366",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide

AU - Crommentuyn, K.M.L.

AU - Schellens, J.H.M.

AU - van den Berg, J.D.

AU - Beijnen, J.H.

PY - 1998

Y1 - 1998

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0305-7372

VL - 24

SP - 345

EP - 366

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

ER -